2022 - Pharmacy Technician Pulse

Novel medicines approved in 2022 offer increased treatment options for patients

PhRMA

JANUARY 23, 2023

2022 marked another year of significant progress by biopharmaceutical research companies conducting lifesaving research and development for innovative medicines with a total of 45 new medicine approvals by the U.S. Food and Drug Administration (FDA).

FDA

Providers 'wasted' $10.6B in 2022 overturning claims denials, survey finds

Fierce Healthcare

MARCH 21, 2024

More than 100 provider organizations want the Centers for Medicare & Medicaid Services (CMS) to take a tougher stance on Medicare Advantage (MA) plans’ practices following an industry survey es | Providers spent nearly $20 billion in 2022 pursuing delays and denials across all payer types, yet those efforts are substantially more costly on average (..)

Hospitals

Cardiovascular Mortality Rates Increased From 2020 to 2022, Correlating With Pandemic

Pharmacy Times

FEBRUARY 7, 2024

Investigators also found that the mortality rates for cardiovascular disease from 2020 to 2022 reversed the improvements of reduced mortalities in the preceding decades.

Congratulations to our 2022 Working for Cures Employee Champions

PhRMA

NOVEMBER 10, 2022

The Working for Cures Employee Champion Awards celebrate the real people in our industry who go above and beyond to advance science and support the work our industry does for patients.

Looking to the Southern Hemisphere for Clue’s on the 2022-2023 Flu Season

Drug Topics

OCTOBER 4, 2022

Does the severe flu season in the southern hemisphere hint at a tough season for the north?

2022-2023 Flu Season Vaccination Recommendations for Children and Adolescents

Drug Topics

SEPTEMBER 7, 2022

Keep your pharmacy vaccine-ready for your youngest patients with the most current influenza vaccination information from the American Academy of Pediatrics.

Vaccines

U.S. government spent more on health care in 2022 than six countries with universal health care combined

STAT

DECEMBER 19, 2023

trillion in federal and state health care expenditures in 2022 — about 41% of the nearly $4.5 American taxpayers footed the bill for at least $1.8 trillion in both public and private health care spending the U.S. recorded last year, according to the annual report released last week by the Centers for Medicare and Medicaid Services.

Insurance

2022-2023 Influenza Season Classified as High Severity by CDC

Drug Topics

NOVEMBER 29, 2023

This season marks the fourth to be classified as high severity since the 2009 influenza A(H1N1) pandemic.

340B program reaches $100 billion in sales, while patients are left behind

PhRMA

JUNE 14, 2023

The 340B Drug Pricing Program has grown yet again , exceeding $100 billion in sales in 2022 when 340B-priced medicines are measured at wholesale acquisition cost. year-over-year in 2022, continuing a trend in which 340B sales have almost doubled since 2018, outpacing growth of the total U.S. Recent data from IQVIA shows 340B grew 12.2%

Retail Community Pharmacist Wages Declined from 2012 to 2022

Drug Topics

APRIL 30, 2024

Researchers addressed the wage gaps in specific pharmacy settings in relation to big chain retail pharmacy mergers.

STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds

STAT

DECEMBER 11, 2023

During 2022, drugmakers substantially raised prices on eight widely used medicines without any new clinical evidence to justify the increases, leading patients and health insurers in the U.S. to spend an additional $1.2 billion last year, according to a new report.

Insurance

ICYMI: PhRMA COO Lori Reilly speaks about the health care agenda for the next Congress

PhRMA

DECEMBER 9, 2022

On December 7, 2022, PhRMA sponsored the Axios event, “ The Post-Midterm Health Care Agenda ,” where I participated in a View from the Top segment with Nicholas Johnston, publisher of Axios. With a divided Congress, bipartisan action will be necessary to move the needle on health care policy.

Insurance

RAND: Hospitals charged insurers 254% more than Medicare rates in 2022

Fierce Healthcare

MAY 13, 2024

The gap between insurance plans and Medicare's payments to hospitals for inpatient and outpatient services widened over the course of just a couple of years, a new study from RAND Corporation | A new report from RAND Corporation highlighted just how much more employers and private insurers are paying hospitals for inpatient and outpatient services. (..)

Insurance

Insurance Hospitals

U.S. biopharmaceutical exports support jobs, innovation

PhRMA

MARCH 20, 2023

exports of goods exceeded $2 trillion in 2022. exports of pharmaceutical preparations exceeded $90 billion in 2022 — an increase of $7 billion over the previous year. Bureau of Economic Analysis recently published annual trade data indicating that U.S. According to the report, U.S. Recent PhRMA comments to the U.S.

Examining the Impact of the Roe v Wade Decision on Medication Access

Drug Topics

DECEMBER 12, 2022

Investigators set out to evaluate how medication access for certain rheumatic conditions has changed since June 2022.

Teen Drug Overdose Deaths on the Rise

Drug Topics

JANUARY 3, 2023

The CDC has reported an increase in drug overdose deaths from 2019 to 2022 in adolescents aged 10 to 19 years.

STAT+: Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition

STAT

APRIL 15, 2024

Ultragenyx has found early success with its experimental treatment for the rare disease Angelman syndrome, supporting the company’s decision to acquire its development partner two years ago.

Communication

Pharmacy Staffing Shortages Lead to Disruptions in Patient Care

Drug Topics

AUGUST 25, 2023

A 2022 survey conducted by the National Community Pharmacists Association reported that more than 70% of pharmacies were struggling to fill staff positions.

Patient Care

The Price of New Cancer Drugs Continues To Rise

Drug Topics

JUNE 7, 2023

The median annual cost for new oncology medicines launched in 2022 was $260,000, up from $63,534 10 years ago, an IQVIA report finds.

MorningRX: August 11, 2023

Drug Topics

AUGUST 11, 2023

HHS awards money to fight the nursing shortage, the FDA approves Johnson & Johnson's talquetamab-tgvs (TALVEY), and the CDC says suicides reached an all-time high in 2022.

FDA

Expert: Deprescribing Is an Important Part of End-of-Life Care

Pharmacy Times

NOVEMBER 7, 2022

A session presenter at the ASCP 2022 Annual Meeting addresses research investigating the value of preventative treatments when patients have a limited life expectancy.

Sparking conversations — and careers — at the 2nd annual Pathways to Success Summit

PhRMA

DECEMBER 8, 2022

On September 28-29, 2022, PhRMA hosted the second annual Pathways to Success: Virtual Graduate Summit and Career Expo. This event provided a unique opportunity for students and faculty from diverse backgrounds to engage with biopharma recruiters and employees.

FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6

Drug Topics

MARCH 28, 2024

Tenofovir alafenamide was originally approved by the FDA in 2016 to treat adults with chronic HBV infection with compensated liver disease and in 2022 to treat pediatric patients aged 12 years and older.

FDA

Centene boosts guidance amid 'stronger than expected' marketplace enrollment

Fierce Healthcare

FEBRUARY 6, 2024

Centene posted $45 million in profit for the fourth quarter of 2023, with its profitability for the full year growing notably compared to 2022. Centene posted $45 million in profit for the fourth quarter of 2023, with its profitability for the full year growing notably compared to 2022.

Overdose deaths hit another record but show signs of leveling off

STAT

MARCH 20, 2024

recorded 107,941 drug overdose deaths in 2022, according to a new federal report — a total that marks an all-time record but also shows signs that the country’s overdose rate may finally be leveling off after years of steady increase.

STAT+: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion

STAT

SEPTEMBER 30, 2024

billion combined last year, compared with $4 billion in 2022. million in 2022. But the biggest names in health care still made $3.5 The average chief executive brought home $11 million, while the median was $4.1 Those figures compared to an average of $13 million and median of $4.3

Pharmaceutical Companies

Pharmaceutical Companies Pharmaceutical Companies Hospitals Insurance

High-flying Vertex hikes CEO Reshma Kewalramani's pay by 30% to $20.6M

Fierce Pharma

APRIL 5, 2024

million pay in 2022. Vertex CEO Reshma Kewalramani, M.D., million in 2023, which was an increase of 30% from her $15.9

Nearly 80% of docs employed by hospitals, corporate entities in continued shift away from independent practice

Fierce Healthcare

APRIL 11, 2024

The decadelong decline of independent physicians rolled on in 2022 and 2023 with a new high of 77.6% increase over early 2022 and a continuation of a decadelong trend, according to a new report.

Hospitals

The 20 highest paid specialties in 2023 as doctors see 6% boost in pay: Doximity

Fierce Healthcare

MAY 23, 2024

After several years of modest or declining growth, the average pay for doctors jumped 5.9% in 2023, rebounding from a decline of 2.4% After several years of modest or declining growth, the average pay for doctors jumped 5.9% in 2023, rebounding from a decline of 2.4%

Congenital syphilis cases in the U.S. have skyrocketed, CDC says

STAT

NOVEMBER 7, 2023

The number of cases of congenital syphilis in 2022 was more than 10 times the number recorded in 2012, the agency said, noting that most of the 3,761 cases reported in 2022 could have been averted, if the babies’ mothers had been adequately tested and treated. Read the rest…

Lyme disease cases rise, but largely due to a change in data collection

STAT

FEBRUARY 15, 2024

A new report released Thursday by the Centers for Disease Control and Prevention appears to show that Lyme disease cases in the United States rose by 69% in 2022 over previous years. The change, an attempt to lift a crushing reporting burden off the shoulders of states where Lyme disease infections are common, went into effect in 2022.

Opinion: To reduce suicide, primary care and mental health clinicians need to work together. Congress can help that happen

STAT

JUNE 24, 2024

Suicide rates in the United States increased approximately 36% between 2000 and 2022, according to updated data from the National Center for Health Statistics. Suicide was responsible for just under 50,000 deaths in 2022 (the last year with complete statistics) — an all-time high.

What will it take to end health care worker burnout?

STAT

OCTOBER 26, 2023

Researchers compared survey data from 2018 and 2022, finding that health workers experienced poorer mental health outcomes post-pandemic. Of those surveyed, 46% of health workers reported feeling burnout often or very often in 2022, compared to 32% in 2018. Read the rest…

Hospitals

Drug overdose deaths fell for first time in five years, though still exceeded 100,000

STAT

MAY 15, 2024

drug overdose deaths, according to preliminary statistics released Wednesday by the Centers for Disease Control and Prevention, roughly a 3% drop from 2022. Last year saw 107,543 U.S. Read the rest…

Arcutis' Zoryve bags 2nd FDA nod, this time as a foam to treat 'the great neglected disease in dermatology'

Fierce Pharma

DECEMBER 15, 2023

About a year after Arcutis Biotherapeutics unveiled positive data on roflumilast foam at the European Academy of Dermatology and Venereology congress 2022, the company has clinched a second FDA OK.

FDA

Five Things Pharmacists Should Know About Ventilator Associated Pneumonia (VAP)

IDStewardship

DECEMBER 1, 2022

Article Posted 1 December 2022. Published by IDSA 3/31/2022. In this article a pharmacist with advanced training and experience in infectious diseases discusses five things pharmacists should know about ventilator associated pneumonia (VAP). Authored By: Lucia Rose, PharmD, BCIDP. Tamma, Samuel L. Aitken, Robert A. Bonomo, et al.

Hospitals

With Pfizer struggling in 2023, CEO Bourla hit with 35% pay cut to $21.6M

Fierce Pharma

MARCH 15, 2024

After a difficult year for Pfizer, in which its share price fell by 44%, CEO Albert Bourla’s compensation fell by 35% from $33 million in 2022 to $21.6 But even the drugmaker was surprised by the plummeting demand for its COVID-19 products, missing badly on its 2023 guidance. million in 2023.

The U.S. hasn’t seen syphilis numbers this high since 1950. Other STD rates are down or flat

STAT

JANUARY 30, 2024

syphilis epidemic isn’t abating, with the rate of infectious cases rising 9% in 2022, according to a new federal government report on sexually transmitted diseases in adults. NEW YORK — The U.S. But there’s some unexpected good news: The rate of new gonorrhea cases fell for the first time in a decade.

Study Highlights Impact of Preventive Strategies for RSV Hospitalizations in Pediatric Patients

Pharmacy Times

OCTOBER 5, 2023

Study shows a a significant burden of hospitalizations associated with respiratory syncytial virus during the 2021-2022 season compared with the prepandemic period.

Hospitals

Appeals court revives $411M antitrust class action against Sutter Health

Fierce Healthcare

JUNE 5, 2024

An appellate court panel has resuscitated a nine-figure antitrust class-action lawsuit against Sutter Health, ruling Tuesday that a 2022 jury was given improper instructions and that a new trial mu | The decadelong case had been unanimously ruled in the nonprofit system's favor back in 2022.

Antiviral used for mpox no better than placebo, NIH says

STAT

AUGUST 15, 2024

The results are notable because the drug, tecovirimat, has rarely been studied clinically for mpox, despite its sporadic use over the years in parts of Africa and its wider use during the 2022 and 2023 outbreaks in the U.S. and Europe. Read the rest…

As Covid deaths drop, heart disease and cancer remain leading causes of death

STAT

AUGUST 8, 2024

lower than 2022. Heart disease and cancer remained the first and second leading causes of death, followed by unintentional injuries as No. Overall, deaths in 2023 were 6.1% Read the rest…

Bavarian Nordic scores $157M contract to replenish US supplies of smallpox/mpox vaccine Jynneos

Fierce Pharma

AUGUST 8, 2024

million to “partly replenish” Jynneos vaccine stocks in response to the 2022 outbreak of mpox, the disease formerly known as monkeypox. . | The Biomedical Advanced Research and Development Authority (BARDA) is handing Bavarian Nordic $156.8

Vaccines

Roche scores FDA nod for prefilled syringe version of Vabysmo, easing its administration

Fierce Pharma

JULY 8, 2024

Since Roche gained approval for its eye disease medication Vabysmo in 2022, it has stormed a market dominated by Regeneron and Bayer’s Eylea. Since Roche gained approval for its eye disease medication Vabysmo in 2022, it has stormed a market dominated by Regeneron and Bayer’s Eylea.

FDA

Novel medicines approved in 2022 offer increased treatment options for patients

Providers 'wasted' $10.6B in 2022 overturning claims denials, survey finds

Trending Sources

Cardiovascular Mortality Rates Increased From 2020 to 2022, Correlating With Pandemic

Congratulations to our 2022 Working for Cures Employee Champions

Looking to the Southern Hemisphere for Clue’s on the 2022-2023 Flu Season

2022-2023 Flu Season Vaccination Recommendations for Children and Adolescents

U.S. government spent more on health care in 2022 than six countries with universal health care combined

2022-2023 Influenza Season Classified as High Severity by CDC

340B program reaches $100 billion in sales, while patients are left behind

Retail Community Pharmacist Wages Declined from 2012 to 2022

STAT+: The prices of 8 drugs were hiked without proof of new benefits, costing the U.S. $1.2 billion in 2022, report finds

ICYMI: PhRMA COO Lori Reilly speaks about the health care agenda for the next Congress

RAND: Hospitals charged insurers 254% more than Medicare rates in 2022

U.S. biopharmaceutical exports support jobs, innovation

Examining the Impact of the Roe v Wade Decision on Medication Access

Teen Drug Overdose Deaths on the Rise

STAT+: Ultragenyx reports early success with Angelman syndrome drug, backing up 2022 acquisition

Pharmacy Staffing Shortages Lead to Disruptions in Patient Care

The Price of New Cancer Drugs Continues To Rise

MorningRX: August 11, 2023

Expert: Deprescribing Is an Important Part of End-of-Life Care

Sparking conversations — and careers — at the 2nd annual Pathways to Success Summit

FDA Expands Tenofovir Alafenamide Indication to Treat HBV in Patients as Young as 6

Centene boosts guidance amid 'stronger than expected' marketplace enrollment

Overdose deaths hit another record but show signs of leveling off

STAT+: Health care CEOs dialed back their pay in 2023. They still made $3.5 billion

High-flying Vertex hikes CEO Reshma Kewalramani's pay by 30% to $20.6M

Nearly 80% of docs employed by hospitals, corporate entities in continued shift away from independent practice

The 20 highest paid specialties in 2023 as doctors see 6% boost in pay: Doximity

Congenital syphilis cases in the U.S. have skyrocketed, CDC says

Lyme disease cases rise, but largely due to a change in data collection

Opinion: To reduce suicide, primary care and mental health clinicians need to work together. Congress can help that happen

What will it take to end health care worker burnout?

Drug overdose deaths fell for first time in five years, though still exceeded 100,000

Arcutis' Zoryve bags 2nd FDA nod, this time as a foam to treat 'the great neglected disease in dermatology'

Five Things Pharmacists Should Know About Ventilator Associated Pneumonia (VAP)

With Pfizer struggling in 2023, CEO Bourla hit with 35% pay cut to $21.6M

The U.S. hasn’t seen syphilis numbers this high since 1950. Other STD rates are down or flat

Study Highlights Impact of Preventive Strategies for RSV Hospitalizations in Pediatric Patients

Appeals court revives $411M antitrust class action against Sutter Health

Antiviral used for mpox no better than placebo, NIH says

As Covid deaths drop, heart disease and cancer remain leading causes of death

Bavarian Nordic scores $157M contract to replenish US supplies of smallpox/mpox vaccine Jynneos

Roche scores FDA nod for prefilled syringe version of Vabysmo, easing its administration

Stay Connected